Pharmacokinetics of ferric bepectate—a new intravenous iron drug for treating iron deficiency

IV iron is indicated in clinical conditions, where rapid anaemia alleviation and repletion of iron stores are required. The acute toxicity of IV iron is ascribed to the presence of labile iron in plasma. Thus, shorter plasma residence time might improve the safety profile, even for compounds holding...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz, Manuel, Olsen, Peter Skov, Petersen, Tonny Studsgaard, Manhart, Susanne, Waldorff, Stig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849879/
https://www.ncbi.nlm.nih.gov/pubmed/30839153
http://dx.doi.org/10.1111/bcpt.13219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849879/
https://www.ncbi.nlm.nih.gov/pubmed/30839153
http://dx.doi.org/10.1111/bcpt.13219

Ejemplares similares